Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: The complex pathogenesis of Alzheimer's disease (AD) has resulted in limited current biomarkers for its classification and diagnosis, necessitating further investigation into reliable universal biomarkers or combinations.
INTRODUCTION: Early-onset Alzheimer's disease (EOAD) population is a clinically, genetically and pathologically heterogeneous condition. Identifying biomarkers related to disease progression is crucial for advancing clinical trials and improving therapeutic strategies. This study aims to differentiate EOAD patients with varying rates of progression using Brain Age Gap Estimation (BrainAGE)-based c...
Accurately predicting cognitive scores based on structural MRI holds significant clinical value for understanding the pathological stages of dementia ...
Machine Learning (ML) is a promising approach for predicting outcomes of youth anxiety treatments. To this end, data from nine randomized controlled t...
Parkinson's disease (PD), a progressive neurodegenerative disorder, affects millions globally, with cognitive impairment as a significant non-motor co...
Vascular dementia (VaD), the second most common form of dementia, lacks reliable biomarkers for early diagnosis. Here, we integrated weighted gene co-...
Alzheimer's Disease (AD) is a prevalent neurodegenerative condition where early detection is vital. Handwriting, often affected early in AD, offers a ...
BACKGROUND: The rising prevalence of dementia is a major concern, with approximately 45% of cases linked to 14 modifiable risk factors. The European p...
A healthy diet has been associated with a reduced risk of dementia. Here we devised a Machine learning-assisted Optimizing Dietary intERvention agains...
Alzheimer's disease (AD) constitutes a neurodegenerative disorder predominantly observed in the geriatric population. If AD can be diagnosed early, bo...
Dementia typically results from damage to neural pathways and the consequent degeneration of neuronal connections. Graph neural networks (GNNs) have b...
We propose a compositional graph-based Machine Learning (ML) framework for Alzheimer's disease (AD) detection that constructs complex ML predictors fr...
Early diagnosis of Neurological Disorders (ND) such as Alzheimer's disease (AD) and Brain Tumors (BT) can be highly challenging since these diseases c...
Traditional diagnostic methods for Alzheimer's disease often suffer from low accuracy and lengthy processing times, delaying crucial interventions and...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that significantly impacts cognitive function, posing a major global health chall...
Vascular cognitive impairment (VCI) is an umbrella term for diseases associated with cognitive decline induced by substantive brain damage following p...
The current depth of site-specific N-glycoproteomics is insufficient to fully characterize glycosylation events in biological samples. Herein, we achi...
Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's disease (PD), are a growing global health concern, especially am...
This study developed machine learning models to predict Aβ positivity in Alzheimer's disease by integrating early-phase F-Florbetaben PET and clinical...
This paper introduces supervised learning techniques for real-time selection (triggering) of hadronically decaying tau leptons in proton-proton collid...